טוען...
Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers
Technologies that facilitate the targeted manipulation of epigenetic marks could be used to precisely control cell phenotype or interrogate the relationship between the epigenome and transcriptional control. Here we have generated a programmable acetyltransferase based on the CRISPR/Cas9 gene regula...
שמור ב:
| הוצא לאור ב: | Nat Biotechnol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4430400/ https://ncbi.nlm.nih.gov/pubmed/25849900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.3199 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|